Drugs / TD101
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00716014 Comparator | Jan → Aug 2008 | pachyonychia congenita | Pachyonychia Congenita Project | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TD101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00716014 ↗ |
| Modality | Small interfering RNA (siRNA) | “a small interfering RNA (siRNA) that specifically targets a mutation in one of the PC keratins, K6a” NCT00716014 ↗ |
| Route | Other | “TD101 is injection into a callus on the bottom of one of the patient's feet” NCT00716014 ↗ |